Cargando…

Vaccine Hesitancy

PURPOSE OF REVIEW: The recent COVID-19 pandemic has caused over 800,000 deaths in the USA as of this writing. Remarkable, several effective vaccines have been developed within 1 year of the occurrence of the pandemic’s outbreak in the USA. RECENT FINDINGS: Although the vaccine has proven to be remar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagliaferro, Joseph, Glauser, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972757/
https://www.ncbi.nlm.nih.gov/pubmed/35382383
http://dx.doi.org/10.1007/s40138-022-00243-2
_version_ 1784679916527157248
author Tagliaferro, Joseph
Glauser, Jonathan
author_facet Tagliaferro, Joseph
Glauser, Jonathan
author_sort Tagliaferro, Joseph
collection PubMed
description PURPOSE OF REVIEW: The recent COVID-19 pandemic has caused over 800,000 deaths in the USA as of this writing. Remarkable, several effective vaccines have been developed within 1 year of the occurrence of the pandemic’s outbreak in the USA. RECENT FINDINGS: Although the vaccine has proven to be remarkably effective in preventing hospitalization and death, the number of unvaccinated persons in the USA who are eligible for the vaccine remains over 35%. SUMMARY: Unvaccinated persons pose a risk for vaccine mutation and prolongation of the pandemic, with its attendant quarantines and societal shutdowns. The ability of clinicians to address this problem remains unclear in a population suspicious of science and of the health care community.
format Online
Article
Text
id pubmed-8972757
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-89727572022-04-01 Vaccine Hesitancy Tagliaferro, Joseph Glauser, Jonathan Curr Emerg Hosp Med Rep Infectious Disease (J Glauser, Section Editor) PURPOSE OF REVIEW: The recent COVID-19 pandemic has caused over 800,000 deaths in the USA as of this writing. Remarkable, several effective vaccines have been developed within 1 year of the occurrence of the pandemic’s outbreak in the USA. RECENT FINDINGS: Although the vaccine has proven to be remarkably effective in preventing hospitalization and death, the number of unvaccinated persons in the USA who are eligible for the vaccine remains over 35%. SUMMARY: Unvaccinated persons pose a risk for vaccine mutation and prolongation of the pandemic, with its attendant quarantines and societal shutdowns. The ability of clinicians to address this problem remains unclear in a population suspicious of science and of the health care community. Springer US 2022-04-01 2022 /pmc/articles/PMC8972757/ /pubmed/35382383 http://dx.doi.org/10.1007/s40138-022-00243-2 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Infectious Disease (J Glauser, Section Editor)
Tagliaferro, Joseph
Glauser, Jonathan
Vaccine Hesitancy
title Vaccine Hesitancy
title_full Vaccine Hesitancy
title_fullStr Vaccine Hesitancy
title_full_unstemmed Vaccine Hesitancy
title_short Vaccine Hesitancy
title_sort vaccine hesitancy
topic Infectious Disease (J Glauser, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972757/
https://www.ncbi.nlm.nih.gov/pubmed/35382383
http://dx.doi.org/10.1007/s40138-022-00243-2
work_keys_str_mv AT tagliaferrojoseph vaccinehesitancy
AT glauserjonathan vaccinehesitancy